Slower infusion of metoclopramide decreases the rate of akathisia

Linda Regan, Robert S. Hoffman, Lewis S. Nelson

Research output: Contribution to journalArticle

Abstract

Objective: We investigated the difference in incidence of acute akathisia related to the rate of infusion in patients receiving metoclopramide for acute nausea, vomiting, or migraine headache in the emergency department (ED). Methods: Randomized, prospective, double-blind clinical trial of patients aged 18 years and older who were to receive intravenous metoclopramide for the treatment of nausea, vomiting, or headache were eligible. Patients were excluded if they were taking medications that might mimic or mask akathisia, had a movement disorder, renal insufficiency, or were unable or unwilling to consent. Pregnant women and prisoners were also excluded. Subjects were randomized to receive 1 of 2 accepted metoclopramide administration regimens. The regimens included 10 mg of metoclopramide administered either as a 2-minute bolus (BG) or as a slow infusion for 15 minutes (IG). All patients received a normal saline placebo at the opposite rate to maintain blinding. The main outcome was development of akathisia noted at 60 minutes after drug administration as measured either with The Prince Henry Hospital akathisia rating scale or by sudden unexplained departure from the ED during treatment. Results: One hundred twenty-seven patients were eligible for the study. Fifty-nine patients met exclusion criteria. Of the remaining 68 patients, 36 were randomized to the BG and 32 were randomized to the IG. In the BG, 11.1% of patients developed akathisia compared with 0% in the IG (P = .026). Four patients developed akathisia based on the scale and 2 departed suddenly from the ED. Conclusions: Slower infusion of metoclopramide reduces the incidence of akathisia.

Original languageEnglish (US)
Pages (from-to)475-480
Number of pages6
JournalAmerican Journal of Emergency Medicine
Volume27
Issue number4
DOIs
StatePublished - May 2009

Fingerprint

Psychomotor Agitation
Metoclopramide
Hospital Emergency Service
Nausea
Vomiting
Prisoners
Incidence
Movement Disorders
Masks
Migraine Disorders
Renal Insufficiency
Headache
Pregnant Women
Placebos
Clinical Trials

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Slower infusion of metoclopramide decreases the rate of akathisia. / Regan, Linda; Hoffman, Robert S.; Nelson, Lewis S.

In: American Journal of Emergency Medicine, Vol. 27, No. 4, 05.2009, p. 475-480.

Research output: Contribution to journalArticle

Regan, Linda ; Hoffman, Robert S. ; Nelson, Lewis S. / Slower infusion of metoclopramide decreases the rate of akathisia. In: American Journal of Emergency Medicine. 2009 ; Vol. 27, No. 4. pp. 475-480.
@article{749ebf9337c84e3da5b447ff6f1664f6,
title = "Slower infusion of metoclopramide decreases the rate of akathisia",
abstract = "Objective: We investigated the difference in incidence of acute akathisia related to the rate of infusion in patients receiving metoclopramide for acute nausea, vomiting, or migraine headache in the emergency department (ED). Methods: Randomized, prospective, double-blind clinical trial of patients aged 18 years and older who were to receive intravenous metoclopramide for the treatment of nausea, vomiting, or headache were eligible. Patients were excluded if they were taking medications that might mimic or mask akathisia, had a movement disorder, renal insufficiency, or were unable or unwilling to consent. Pregnant women and prisoners were also excluded. Subjects were randomized to receive 1 of 2 accepted metoclopramide administration regimens. The regimens included 10 mg of metoclopramide administered either as a 2-minute bolus (BG) or as a slow infusion for 15 minutes (IG). All patients received a normal saline placebo at the opposite rate to maintain blinding. The main outcome was development of akathisia noted at 60 minutes after drug administration as measured either with The Prince Henry Hospital akathisia rating scale or by sudden unexplained departure from the ED during treatment. Results: One hundred twenty-seven patients were eligible for the study. Fifty-nine patients met exclusion criteria. Of the remaining 68 patients, 36 were randomized to the BG and 32 were randomized to the IG. In the BG, 11.1{\%} of patients developed akathisia compared with 0{\%} in the IG (P = .026). Four patients developed akathisia based on the scale and 2 departed suddenly from the ED. Conclusions: Slower infusion of metoclopramide reduces the incidence of akathisia.",
author = "Linda Regan and Hoffman, {Robert S.} and Nelson, {Lewis S.}",
year = "2009",
month = "5",
doi = "10.1016/j.ajem.2008.03.044",
language = "English (US)",
volume = "27",
pages = "475--480",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Slower infusion of metoclopramide decreases the rate of akathisia

AU - Regan, Linda

AU - Hoffman, Robert S.

AU - Nelson, Lewis S.

PY - 2009/5

Y1 - 2009/5

N2 - Objective: We investigated the difference in incidence of acute akathisia related to the rate of infusion in patients receiving metoclopramide for acute nausea, vomiting, or migraine headache in the emergency department (ED). Methods: Randomized, prospective, double-blind clinical trial of patients aged 18 years and older who were to receive intravenous metoclopramide for the treatment of nausea, vomiting, or headache were eligible. Patients were excluded if they were taking medications that might mimic or mask akathisia, had a movement disorder, renal insufficiency, or were unable or unwilling to consent. Pregnant women and prisoners were also excluded. Subjects were randomized to receive 1 of 2 accepted metoclopramide administration regimens. The regimens included 10 mg of metoclopramide administered either as a 2-minute bolus (BG) or as a slow infusion for 15 minutes (IG). All patients received a normal saline placebo at the opposite rate to maintain blinding. The main outcome was development of akathisia noted at 60 minutes after drug administration as measured either with The Prince Henry Hospital akathisia rating scale or by sudden unexplained departure from the ED during treatment. Results: One hundred twenty-seven patients were eligible for the study. Fifty-nine patients met exclusion criteria. Of the remaining 68 patients, 36 were randomized to the BG and 32 were randomized to the IG. In the BG, 11.1% of patients developed akathisia compared with 0% in the IG (P = .026). Four patients developed akathisia based on the scale and 2 departed suddenly from the ED. Conclusions: Slower infusion of metoclopramide reduces the incidence of akathisia.

AB - Objective: We investigated the difference in incidence of acute akathisia related to the rate of infusion in patients receiving metoclopramide for acute nausea, vomiting, or migraine headache in the emergency department (ED). Methods: Randomized, prospective, double-blind clinical trial of patients aged 18 years and older who were to receive intravenous metoclopramide for the treatment of nausea, vomiting, or headache were eligible. Patients were excluded if they were taking medications that might mimic or mask akathisia, had a movement disorder, renal insufficiency, or were unable or unwilling to consent. Pregnant women and prisoners were also excluded. Subjects were randomized to receive 1 of 2 accepted metoclopramide administration regimens. The regimens included 10 mg of metoclopramide administered either as a 2-minute bolus (BG) or as a slow infusion for 15 minutes (IG). All patients received a normal saline placebo at the opposite rate to maintain blinding. The main outcome was development of akathisia noted at 60 minutes after drug administration as measured either with The Prince Henry Hospital akathisia rating scale or by sudden unexplained departure from the ED during treatment. Results: One hundred twenty-seven patients were eligible for the study. Fifty-nine patients met exclusion criteria. Of the remaining 68 patients, 36 were randomized to the BG and 32 were randomized to the IG. In the BG, 11.1% of patients developed akathisia compared with 0% in the IG (P = .026). Four patients developed akathisia based on the scale and 2 departed suddenly from the ED. Conclusions: Slower infusion of metoclopramide reduces the incidence of akathisia.

UR - http://www.scopus.com/inward/record.url?scp=65449187521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65449187521&partnerID=8YFLogxK

U2 - 10.1016/j.ajem.2008.03.044

DO - 10.1016/j.ajem.2008.03.044

M3 - Article

VL - 27

SP - 475

EP - 480

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 4

ER -